Seyed Peyman Shariatpanahi

Dr. Seyed Peyman Shariatpanahi

University of Tehran, Tehran, Iran
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
SSSeyed Peyman Shariatpanahi
Seyed Peyman Shariatpanahi
SSSeyed Pooya Shariatpanahi
Seyed Pooya Shariatpanahi
KMKeivan Majidzadeh-A
Keivan Majidzadeh-A
Moustapha HassanMoustapha Hassan
Moustapha Hassan
MAManuchehr Abedi-Valugerdi
Manuchehr Abedi-Valugerdi

1 January 2016 in Measurement
Verified
Journal Article
Closed access
MMMohammad Mohammadiaria
Mohammad Mohammadiaria
Azam Iraji zadAzam Iraji zad
Azam Iraji zad
FAFatemeh Razi Astaraei
Fatemeh Razi Astaraei
SSSeyed Peyman Shariatpanahi
Seyed Peyman Shariatpanahi
RSReza Sarvari
Reza Sarvari

5 October 2011 in Soft Matter
Verified
Journal Article
Open access
PDF file
SSSeyed Peyman Shariatpanahi
Seyed Peyman Shariatpanahi
Azam Iraji zadAzam Iraji zad
Azam Iraji zad
IAIman Abdollahzadeh
Iman Abdollahzadeh
RSR. Shirsavar
R. Shirsavar
DBDaniel Bonn
Daniel Bonn
RER. Ejtehadi
R. Ejtehadi
Direct near field electrospinning is used to produce very long helical polystyrene microfibers in water. The pitch length of helices can be controlled by changing the applied voltage, allowing the production of both microsprings and microchannels. Using a novel high frequency variable voltage electrospinning method we determined the helix formation speed and compared the experimental buckling frequency to theoretical expressions for viscous and elastic buckling. Finally we showed that the new method can be used to produce new periodic micro and nano structures.

20 August 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MNMaryam Sadat Nezamtaheri
Maryam Sadat Nezamtaheri
BGBahram Goliaei
Bahram Goliaei
SSSeyed Peyman Shariatpanahi
Seyed Peyman Shariatpanahi
AAAlireza Madjid Ansari
Alireza Madjid Ansari
Extremely low-frequency electromagnetic field (ELF-EMF) induces biological effects on different cells through various signaling pathways. To study the impact of the ELF-EMF on living cells under an optimal physiological condition, we have designed and constructed a novel system that eliminates several limitations of other ELF-EMF systems. Apoptosis and cell number were assessed by flow cytometry and the Trypan Blue dye exclusion method, respectively. In vitro cell survival was evaluated by colony formation assay. The distribution of cells in the cell cycle, intracellular ROS level, and autophagy were analyzed by flow cytometer. Suspended cells differentiation was assessed by phagocytosis of latex particles and NBT reduction assay. Our results showed that response to the exposure to ELF-EMF is specific and depends on the biological state of the cell. For DU145, HUVEC, and K562 cell lines the optimum results were obtained at the frequency of 0.01 Hz, while for MDA-MB-231, the optimum response was obtained at 1 Hz. Long-term exposure to ELF-EMF in adherent cells effectively inhibited proliferation by arresting the cell population at the cell cycle G2/M phase and increased intracellular ROS level, leading to morphological changes and cell death. The K562 cells exposed to the ELF-EMF differentiate via induction of autophagy and decreasing the cell number. Our novel ELF-EMF instrument could change morphological and cell behaviors, including proliferation, differentiation, and cell death.

11 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
RMReza Mehdizadeh
Reza Mehdizadeh
SSSeyed Peyman Shariatpanahi
Seyed Peyman Shariatpanahi
BGBahram Goliaei
Bahram Goliaei
SPSanam Peyvandi
Sanam Peyvandi
Curzio RueggCurzio Ruegg
Curzio Ruegg
Triple-negative breast cancer (TNBC) is a molecular subtype of breast malignancy with a poor clinical prognosis. There is growing evidence that some chemotherapeutic agents induce an adaptive anti-tumor immune response. This reaction has been proposed to maintain the equilibrium phase of the immunoediting process and to control tumor growth by immunological cancer dormancy. We recently reported a model of immunological breast cancer dormancy based on the murine 4T1 TNBC model. Treatment of 4T1 cells in vitro with high-dose chemotherapy activated the type I interferon (type I IFN) signaling pathway, causing a switch from immunosuppressive to cytotoxic T lymphocyte-dependent immune response in vivo, resulting in sustained dormancy. Here, we developed a deterministic mathematical model based on the assumption that two cell subpopulations exist within the treated tumor: one population with high type I IFN signaling and immunogenicity and lower growth rate; the other population with low type I IFN signaling and immunogenicity and higher growth rate. The model reproduced cancer dormancy, elimination, and immune-escape in agreement with our previously reported experimental data. It predicted that the injection of dormant tumor cells with active type I IFN signaling results in complete growth control of the aggressive parental cancer cells injected at a later time point, but also of an already established aggressive tumor. Taken together, our results indicate that a dormant cell population can suppress the growth of an aggressive counterpart by eliciting a cytotoxic T lymphocyte-dependent immune response.

1 February 2023 in Trends in Cardiovascular Medicine
Verified
Journal Article
Closed access
DSDanesh Soltani
Danesh Soltani
SSSahar Samimi
Sahar Samimi
AVAli Vasheghani-Farahani
Ali Vasheghani-Farahani
SSSeyed Peyman Shariatpanahi
Seyed Peyman Shariatpanahi
PAParviz Abdolmaleki
Parviz Abdolmaleki
AAAlireza Madjid Ansari
Alireza Madjid Ansari